Imagion Biosystems Limited
IBXXF
$0.01
-$0.025-71.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.76% | 64.02% | -0.22% | 67.84% | 0.48% |
| Total Depreciation and Amortization | -3.85% | -97.95% | 0.16% | -35.21% | -0.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.75% | -170.65% | 0.19% | 486.75% | 0.48% |
| Change in Net Operating Assets | -2.60% | -- | -- | -- | -0.47% |
| Cash from Operations | 2.73% | -621.66% | -0.19% | 93.10% | 0.48% |
| Capital Expenditure | -- | -- | -- | -- | 0.37% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | 0.36% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -100.00% | 0.36% | 150.55% | 0.37% |
| Total Debt Issued | 0.00% | 127.27% | 0.00% | -78.00% | 0.00% |
| Total Debt Repaid | 0.00% | -- | -- | -- | 0.00% |
| Issuance of Common Stock | 0.00% | -- | -- | -- | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -- | -- | -- | 0.00% |
| Cash from Financing | -2.75% | 1,466.48% | 0.28% | -90.22% | -0.48% |
| Foreign Exchange rate Adjustments | -2.50% | 42.86% | 0.00% | 126.17% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.75% | 1,397.27% | 0.20% | 169.24% | 0.54% |
